Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial

Wei L, Lim SG, Xie Q, et al. Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial. Lancet Gastroenterol Hepatol. 2019;4(2):127-134.

Publication Type:

Journal Article

Authors:

Wei, L; Lim, SG; Xie, Q; et, al

Source:

Lancet Gastroenterol Hepatol, Volume 4, Issue 2, p.127-134 (2019)

Cited On:

Export Citation:
RIS Format
Top